4-amino-5-chloro-2-ethoxy-N-((4-(4-fluorobenzyl)-2-morpholinyl)methyl)benzamide,
AS 4370,
AS-4370,
mosapride,
mosapride citrate,
Mosapride UI05MSP015CT,
Mosapride,
112885-41-3,
4-amino-5-chloro-2-ethoxy-N-((4-(4-fluorobenzyl)-2-morpholinyl)methyl)benzamide,
Mosapride [INN],
CHEMBL60889,
Mosapride (INN),
4-amino-5-chloro-2-ethoxy-N-[[4-[(4-fluorophenyl)methyl]-2-morpholinyl]methyl]benzamide,
AK-41276,
4-amino-5-chloro-2-ethoxy-N-[[4-[(4-fluorophenyl)methyl]morpholin-2-yl]methyl]benzamide,
Q-201413,
(+-)-4-Amino-5-chloro-2-ethoxy-N-((4-(p-fluorobenzyl)-2-morpholinyl)methyl)benzamide,
4-amino-5-chloro-2-ethoxy-N-({4-[(4-fluorophenyl)methyl]morpholin-2-yl}methyl)benzamide,
C21H25ClFN3O3,
Moza,
4-amino-5-chloro-2-ethoxy-N-((4-(4-fluorobenzyl)morpholin-2-yl)methyl)benzamide,
4-amino-5-chloro-2-ethoxy-N-[[4-(4-fluorobenzyl)-2-morpholinyl]methyl]benzamide,
4-amino-5-chloro-2-ethoxy-N-{[4-(4-fluorobenzyl)morpholin-2-yl]methyl}benzamide,
4-azanyl-5-chloranyl-2-ethoxy-N-[[4-[(4-fluorophenyl)methyl]morpholin-2-yl]methyl]benzamide,
Mosart (TN),
AC1L3P2Q,
SCHEMBL16417,
GTPL242,
MLS004774042,
Mosapride citrate salt hydrate,
cid_119583,
DTXSID2048408,
BDBM94630,
CHEBI:94373,
CTK8B3325,
KS-00000IOE,
YPELFRMCRYSPKZ-UHFFFAOYSA-N,
BCP06695,
HY-B0189,
ANW-42285,
BBL010131,
MFCD00867430,
PDSP1_001757,
PDSP2_001740,
STK711184,
AKOS005530698,
AC-4523,
AN-6321,
API0025932,
CS-2080,
DB11675,
DS-1071,
MCULE-1051026269,
RL00525,
RL00526,
RTR-002492,
4 CAmino-5-chloro-2-ethoxy-N-((4-(4-fluorobenzyl)-2-morpholinyl)methyl)benzamide,
NCGC00160527-02,
NCGC00160527-05,
BC679722,
BR-41276,
LS-25426,
M687,
SMR003500712,
SY102307,
AB0015343,
AX8017587,
TR-002492,
4CH-009466,
FT-0631065,
ST24028880,
MFCD00867430 (95%),
D08236,
S-4208,
AB00698266-07,
AB00698266_11,
885M413,
A802684,
A802685,
L000932,
SR-01000763405,
W-60401,
I06-1799,
J-002859,
J-514393,
SR-01000763405-4,
(- )-4-Amino-5-chloro-2-ethoxy-N-((4-(p-fluorobenzyl)-2-morpholinyl)methyl)-benzamide,
(- )-4-Amino-5-chloro-2-ethoxy-N-((4-(p-fluorobenzyl)-2-morpholinyl)methyl)-benzamide.,
Mosapride; 4-Amino-5-chloro-2-ethoxy-N-((4-(4-fluorobenzyl)-2-morpholinyl)methyl)benzamide,
4-amino-5-chloro-2-ethoxy-N-[[4-(4-fluorobenzyl)morpholin-2-yl]methyl]benzamide;citric acid,
4-amino-5-chloro-2-ethoxy-N-[[4-[(4-fluorophenyl)methyl]-2-morpholinyl]methyl]benzamide;2-hydroxypropane-1,2,3-tricarboxylic acid,
4-amino-5-chloro-2-ethoxy-N-[[4-[(4-fluorophenyl)methyl]morpholin-2-yl]methyl]benzamide;2-hydroxypropane-1,2,3-tricarboxylic acid,
4-Amino-5-chloro-2-ethoxy-N-[4-(4-fluoro-benzyl)-morpholin-2-ylmethyl]-benzamide; citrate(AS-4370),
4-azanyl-5-chloranyl-2-ethoxy-N-[[4-[(4-fluorophenyl)methyl]morpholin-2-yl]methyl]benzamide;2-oxidanylpropane-1,2,3-tricarboxylic acid,
Mosapride citrate,
Gasmotin,
Mosapride-d5,
UNII-I8MFJ1C0BY,
Mosapride citrate hydrate,
I8MFJ1C0BY,
Mosapride citrate dihydrate,
D06PZN,
MLS001401439,
ACN-S005338,
C21-H25-Cl-F-N3-O3,
CID119584,
AS 4370,
AS-4370,
CS-O-31167,
NCGC00160527-01,
SMR000469200,
1665B,
A1334,
112885-42-4,
(+-)-4-amino-5-chloro-2-ethoxy-n-[[4-(4-fluorobenzyl)-2-morpholinyl]methyl]benzamide,
1246820-66-5,